Sign in
8-K

Current Report

Edgewise Therapeutics, Inc. Filed Acc 0001104659-23-073465

Delisting notice · Executive or director change

  • Item 3.01 Notice of delisting or failure to meet a listing standard
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading tm2319389d1_8k.htm…